Literature DB >> 7764603

Apoptosis of serum-free C2.8 mouse embryo hepatocytic cells caused by hepatocyte growth factor deprivation.

R P Revoltella1, F Borney, B Dal Canto, C M D'Urso.   

Abstract

C2.8 mouse embryo hepatocytic cells, acutely required exogenous hepatocyte growth factor (HGF) to survive and proliferate in serum-free Dulbecco's modified Eagle's medium supplemented with insulin, transferrin and Na-selenite. Greater than 90% of cultured C2.8 cells died within 48 hours from plating in the absence of HGF. Conversely, HGF prolonged maintenance of life and stimulated cell proliferation. Removal of HGF from the medium of cultures that had grown to confluency, also resulted in a rapid decreased cell survival. In the last circumstance, light microscopic observations revealed, with high frequency, morphological features characteristic of apoptosis. DNA within the affected cells underwent rapid fragmentation, revealed as a ladder of DNA fragments in multiples of about 200 base pairs. HGF prevented loss of cell viability, morphological damages and retarded DNA fragmentation in confluent C2.8 cells. Cycloheximide delayed cell death caused by HGF deprivation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7764603     DOI: 10.1007/BF00749971

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  26 in total

1.  "Superinduction" of tyrosine aminotransferase by actinomycin D: a reevaluation.

Authors:  R A Steinberg; B B Levinson; G M Tomkins
Journal:  Cell       Date:  1975-05       Impact factor: 41.582

Review 2.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

Review 3.  Patterns of cell death.

Authors:  N I Walker; B V Harmon; G C Gobé; J F Kerr
Journal:  Methods Achiev Exp Pathol       Date:  1988

4.  Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure.

Authors:  E Gohda; T Yamasaki; H Tsubouchi; M Kurobe; O Sakiyama; H Aoki; N Niidani; S Shin; K Hayashi; S Hashimoto
Journal:  Biochim Biophys Acta       Date:  1990-06-12

5.  Occurrence of cell death (apoptosis) during the involution of liver hyperplasia.

Authors:  A Columbano; G M Ledda-Columbano; P P Coni; G Faa; C Liguori; G Santa Cruz; P Pani
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

6.  Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure.

Authors:  E Gohda; H Tsubouchi; H Nakayama; S Hirono; K Takahashi; M Koura; S Hashimoto; Y Daikuhara
Journal:  Exp Cell Res       Date:  1986-09       Impact factor: 3.905

7.  Partial characterization of a hepatocyte growth factor from rat platelets.

Authors:  W E Russell; J A McGowan; N L Bucher
Journal:  J Cell Physiol       Date:  1984-05       Impact factor: 6.384

8.  Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.

Authors:  E Gohda; H Tsubouchi; H Nakayama; S Hirono; O Sakiyama; K Takahashi; H Miyazaki; S Hashimoto; Y Daikuhara
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

9.  Expression and inducibility of drug-metabolizing enzymes in novel murine liver epithelial cell lines and their ability to activate procarcinogens.

Authors:  M Paolini; E Barone; C Corsi; C Paganin; R P Revoltella
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

10.  Partial inhibition of castration induced ventral prostate regression with actinomycin D and cycloheximide.

Authors:  T Stanisic; R Sadlowski; C Lee; J T Grayhack
Journal:  Invest Urol       Date:  1978-07
View more
  1 in total

1.  Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma.

Authors:  T Fukuura; C Miki; T Inoue; K Matsumoto; H Suzuki
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.